Clinical Trial Update: A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating a tetravalent live attenuated dengue vaccine in flavivirus antibody-naïve children; the study completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Tetravalent live attenuated dengue vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue Fever | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-24